Loading...
XNAS
STAA
Market cap1.32bUSD
Dec 04, Last price  
26.60USD
1D
0.87%
1Q
-4.80%
Jan 2017
145.16%
Name

STAAR Surgical Co

Chart & Performance

D1W1MN
XNAS:STAA chart
P/E
P/S
4.19
EPS
Div Yield, %
Shrs. gr., 5y
0.93%
Rev. gr., 5y
15.89%
Revenues
314m
-2.64%
51,303,00056,282,00059,363,00074,894,00075,345,00054,958,00062,765,00063,783,00072,215,00074,987,00077,123,00082,432,00090,611,000123,954,000150,185,000163,460,000230,472,000284,391,000322,415,000313,901,000
Net income
-20m
L
-11,175,000-15,044,000-15,999,000-23,195,000-6,200,00053,0001,348,000-1,763,000398,000-8,392,000-6,533,000-12,129,000-2,139,0004,968,00014,048,0005,913,00027,511,00039,665,00021,347,000-20,208,000
CFO
16m
+7.75%
-6,976,000-8,647,000-11,184,000-8,228,0001,427,000-4,417,0005,346,0003,217,0003,352,000-7,951,000-2,162,0001,049,0002,853,00012,767,00025,795,00020,951,00043,962,00035,715,00014,594,00015,725,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
IPO date
Feb 24, 1992
Employees
882
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122021‑002020‑002018‑122017‑122016‑122016‑00
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT